SCHEMBL23382486

SCHEMBL23382486

CC(C)(C)OC(=O)c1ccccc1C(=O)OC(C)(C)C(F)(F)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ ADRA1A P35348 1/20 0.37
▸ ADRA1B P35368 1/20 0.37
▸ GRM6 O15303 1/20 0.37
▸ AR P10275 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ AAK1 Q2M2I8 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.34
▸ CRHBP P24387 1/20 0.34
▸ CRHR2 Q13324 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23559560 0.84 PTPN2 (0.40) TSHRALDH1A1HSD17B10TDP1LMNA
Hydrogen Peroxide SCHEMBL29048859 0.84 TSHR (0.48) TSHRALDH1A1HSD17B10TDP1ADRA1A
SCHEMBL23382488 0.83 CA12 (0.46) TSHRALDH1A1HSD17B10TDP1
SCHEMBL30111657 0.82 TSHR (0.50) TSHRALDH1A1HSD17B10TDP1ADRA1A
SCHEMBL109178 0.82 TSHR (0.50) TSHRALDH1A1HSD17B10TDP1ADRA1A
SCHEMBL24360817 0.81 TSHR (0.49) TSHRALDH1A1HSD17B10TDP1LMNA
SCHEMBL23382490 0.80 SCN1A (0.43) ALDH1A1TDP1MEN1KMT2A
SCHEMBL722115 0.79 ALDH1A1 (0.56) TSHRALDH1A1HSD17B10TDP1GRM6
SCHEMBL30339401 0.79 ALDH1A1 (0.56) TSHRALDH1A1HSD17B10TDP1GRM6
SCHEMBL24360786 0.78 ELANE (0.48) TSHRALDH1A1HSD17B10TDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 TSHR 3502/4885ALDH1A1 4322/4885HSD17B10 2325/4885
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS IDUA, SLC6A5, SLC6A9 TSHR 3502/4885ALDH1A1 4322/4885HSD17B10 2325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback